Clinical trial
Gene Therapy to Improve Wound Healing in Patients With Diabetes
NCT00065663 · Tissue Repair Company, Industry · Completed
Key facts
| NCT number | NCT00065663 |
|---|---|
| Title | Gene Therapy to Improve Wound Healing in Patients With Diabetes |
| Official title | Growth Factor Gene Therapy for Wound Healing |
| Lead sponsor | Tissue Repair Company, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Wounds and Injuries, Diabetes, Diabetic Foot Ulcers, Foot Wounds |
| Intervention type | Genetic |
| Interventions | GAM501 |
| Enrollment | 21 |
| Start date | Aug 1, 2002 |
| Completion | Dec 1, 2004 |
| First posted | Jul 31, 2003 |
| Last update posted | Nov 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: